Uncategorized
June 12, 2025 / June 12, 2025 by SFA Team
Tempe, AZ – June 12, 2025 – Nectero Medical, a clinical-stage biotechnology company developing therapies for aneurysmal disease, announced today that the American Medical Association’s CPT Editorial Panel has approved two Category III CPT codes applicable to the Nectero EAST® System procedure via a percutaneous or open approach. This designation represents a key milestone toward […]
Read more »